Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ARC01
- Development stage
- Phase 1
- Lead developer
- Grand Pharmaceutical
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01
Overview
ARC01 is an investigational **mRNA-based therapeutic tumor vaccine** being developed by Grand Pharma for **HPV-16-positive advanced unresectable or recurrent/metastatic solid tumors**. The product is described as a class 1 therapeutic biologic and uses **lipid nanoparticle delivery technology** to deliver mRNA encoding the **HPV-16 E6 and E7 antigens**. After cellular uptake and antigen expression, the vaccine is intended to stimulate **antigen-specific humoral and cellular immune responses** against HPV-16-driven tumors, with immune enhancement supported by the **TriMix immune adjuvant** platform. Publicly described clinical development includes an **open-label, dose-escalation Phase 1 study in China** evaluating safety, tolerability, immunogenicity, pharmacokinetics, and preliminary efficacy in patients with HPV-16-positive advanced solid tumors.
02
Targets
HPV16 E6 oncoproteinHPV16 E7 (Human papillomavirus 16 E7 protein)
Beyond the preview
Go deeper on ARC01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ARC01.